Doctor-Turned-Patient Focuses On What He Can Control After a Lung Cancer Diagnosis at Age 30

Article

Dr. Dan Tran discusses his stage 4 lung cancer diagnosis at age 30, and how he has managed the shift from doctor to the patient with cancer.

Dr. Dan Tran was in residency and about to start a five-month rotation in anesthesia in the fall of 2017 when he developed back pain and numbness in his legs that made walking nearly impossible. After several tests, and just days before Christmas, Tran was diagnosed with stage 4 lung cancer at the age of 30.

CURE® recently spoke with Tran, an oral and maxillofacial surgeon at Virginia Commonwealth University, about how he felt upon receiving his diagnosis at such a young age, and how he’s managed to keep a positive outlook in the years since.

Transcription:

CURE®: What was it like being diagnosed with lung cancer at the age of 30?

Tran: I think it sucks. Everyone gets dealt a different set of cards, and I got dealt a crappy hand, but it kind of depends on what you do with it.

I've always had a pretty laid-back kind of personality and understood that there's things that I can't control and things I can't control. This is something I could not control, but I can control what I do with it. And so, I think that's helped me a lot. I think fixating on things that you can't control is what really ruins you, when that's all you think about.

Being that young, I was like, this isn't fair. Obviously, everyone thinks that. But there's a lot that isn’t fair. I was lucky enough that I at least had a daughter already. Some people who are diagnosed with cancer young, they can’t have kids anymore. I was already married; I had accomplished a lot of things I wanted to. As far as I career aspects, I didn't finish residency yet.

At first, when I had researched lung cancer, I didn't know much about it. And everything I read said, you have six to nine months live. And that was when I went through those stages of denial. I started bargaining. I was like nine months? Man, just give me five years. And so, I think I'm going to get that, thankfully.

Because I just want to see my daughter grow up a little bit because she was so young at the time. She was just a baby and not as fun at that age. But I just wanted to see her kind of grow up and see what she would most likely become, it's still tough to think about it sometimes. But that’s kind of where I'm at right now.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE